Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer

A phase I trial consisting of panobinostat (a HDAC inhibitor), carboplatin and etoposide was condacted in patients with lung cancer. Patients and Methods: Patients received carboplatin AUC5 on day 1 and etoposide 100 mg/m(2) on days 1, 2 and 3, every 21 days. Concurrent oral panobinostat was given 3...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: TARHINI, AHMAD A., ZAHOOR, HARIS, MCLAUGHLIN, BRIAN, GOODING, WILLIAM E., SCHMITZ, JOHN C., SIEGFRIED, JILL M., SOCINSKI, MARK A., ARGIRIS, ATHANASSIOS
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157617/
https://ncbi.nlm.nih.gov/pubmed/24123018
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk